|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.00 EUR | +0.09% |
|
+2.22% | -7.83% |
| 05-11 | Weekly Earnings Calendar |  |
| 05-07 | Genetix Selects Merck KGaA as Sole Testing Provider for Gene Therapies | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 118.5 | 131.25 | 130 |
| Spread/Res. | -4.64% | -13.90% | -13.08% |
| Spread/Supp. | +9.92% | +9.92% | +8.60% |
| Support | 102.8 | 102.8 | 104.05 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MRK Stock
- Charts Merck KGaA
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition